Adam Maeder
Stock Analyst at Piper Sandler
(3.81)
# 694
Out of 5,055 analysts
100
Total ratings
55.22%
Success rate
8.37%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $12 → $9 | $5.00 | +80.00% | 9 | Nov 14, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $4 → $5 | $7.11 | -29.68% | 2 | Nov 7, 2025 | |
| TCMD Tactile Systems Technology | Reiterates: Neutral | $14 → $20 | $23.70 | -15.61% | 4 | Nov 4, 2025 | |
| INSP Inspire Medical Systems | Reiterates: Overweight | $150 → $135 | $86.35 | +56.34% | 16 | Nov 4, 2025 | |
| EW Edwards Lifesciences | Reiterates: Overweight | $90 → $95 | $86.30 | +10.08% | 17 | Oct 31, 2025 | |
| ISRG Intuitive Surgical | Reiterates: Overweight | $595 → $610 | $549.51 | +11.01% | 21 | Oct 22, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $8.5 → $7 | $3.17 | +120.82% | 8 | Aug 13, 2025 | |
| RMD ResMed | Maintains: Neutral | $248 → $270 | $244.46 | +10.45% | 4 | Aug 1, 2025 | |
| RXST RxSight | Maintains: Neutral | $18 → $10 | $9.73 | +2.77% | 2 | Jul 9, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $2.11 | +89.57% | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $133 → $145 | $130.59 | +11.03% | 3 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $20 → $21 | $19.99 | +5.05% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $1.99 | +302.01% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.22 | +125.23% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $0.57 | +3,068.46% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $55.36 | +78.83% | 3 | May 5, 2022 |
Nyxoah
Nov 14, 2025
Reiterates: Overweight
Price Target: $12 → $9
Current: $5.00
Upside: +80.00%
Sight Sciences
Nov 7, 2025
Maintains: Neutral
Price Target: $4 → $5
Current: $7.11
Upside: -29.68%
Tactile Systems Technology
Nov 4, 2025
Reiterates: Neutral
Price Target: $14 → $20
Current: $23.70
Upside: -15.61%
Inspire Medical Systems
Nov 4, 2025
Reiterates: Overweight
Price Target: $150 → $135
Current: $86.35
Upside: +56.34%
Edwards Lifesciences
Oct 31, 2025
Reiterates: Overweight
Price Target: $90 → $95
Current: $86.30
Upside: +10.08%
Intuitive Surgical
Oct 22, 2025
Reiterates: Overweight
Price Target: $595 → $610
Current: $549.51
Upside: +11.01%
Vicarious Surgical
Aug 13, 2025
Maintains: Neutral
Price Target: $8.5 → $7
Current: $3.17
Upside: +120.82%
ResMed
Aug 1, 2025
Maintains: Neutral
Price Target: $248 → $270
Current: $244.46
Upside: +10.45%
RxSight
Jul 9, 2025
Maintains: Neutral
Price Target: $18 → $10
Current: $9.73
Upside: +2.77%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $2.11
Upside: +89.57%
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $130.59
Upside: +11.03%
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $19.99
Upside: +5.05%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $1.99
Upside: +302.01%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.22
Upside: +125.23%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $0.57
Upside: +3,068.46%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $55.36
Upside: +78.83%